Wordt geladen...
Pharmacokinetics of Low and Maintenance Dose Valganciclovir in Kidney Transplant Recipients
Valganciclovir is commonly used for cytomegalovirus (CMV) prophylaxis in renal transplant patients. A fixed dose of 900 mg daily is typically recommended, however, there has never been a formal pharmacokinetic study comparing various doses in renal transplant patients. We therefore compared the phar...
Bewaard in:
| Hoofdauteurs: | , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2008
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2532821/ https://ncbi.nlm.nih.gov/pubmed/18444933 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1600-6143.2008.02220.x |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|